Healthy Body & Mind Program for Older Adults Living With Osteoarthritis and Cognitive Decline

Sponsor
The University of New South Wales (Other)
Overall Status
Recruiting
CT.gov ID
NCT06070818
Collaborator
(none)
20
1
2
10.3
1.9

Study Details

Study Description

Brief Summary

The goal of this pilot randomised clinical trial is to compare a 12-week Healthy Body & Mind Program to usual care in older adults living with cognitive decline and osteoarthritis.

The main questions it aims to answer are:
  • Does the Healthy Body & Mind Program improve health-related quality of life in older adults living with cognitive decline and osteoarthritis (pre/post and intervention/control)?

  • Does the Healthy Body & Mind Program improve other health outcomes (cognition, pain, anxiety/depression, physical function) in older adults living with cognitive decline and osteoarthritis (pre/post and intervention/control)?

Participants will complete a co-designed and multidisciplinary 12-week program that includes physical activity and lifestyle education (nutrition, social activity and managing anxiety/depression). Researchers will compare outcomes between the intervention group and a wait-list control to see if there are difference in outcome measures (quality of life, cognition, pain, anxiety/depression, physical function).

Condition or Disease Intervention/Treatment Phase
  • Other: Healthy Body & Mind Program
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
A randomised trial with a wait-list control.A randomised trial with a wait-list control.
Masking:
Single (Outcomes Assessor)
Masking Description:
The researcher collecting the outcome measures will not know whether the person is in the intervention or control group.
Primary Purpose:
Treatment
Official Title:
Healthy Body & Mind Program: A Pilot Randomised Controlled Trial to Improve Quality of Life, Reduce Pain, and Reduce Dementia Risk in People Living With Cognitive Decline and Osteoarthritis
Actual Study Start Date :
Sep 18, 2023
Anticipated Primary Completion Date :
Jun 26, 2024
Anticipated Study Completion Date :
Jul 28, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Healthy Body & Mind Program: In summary, the program includes two visits to the University of New South Wales (UNSW) Medicine & Health Lifestyle Clinic at the beginning and end of the program for Initial and Final Assessments, and two weekly sessions for 12 weeks (24 sessions in total) to the UNSW Medicine & Health Lifestyle Clinic to complete the Healthy Body & Mind Program. Participants will also be invited to take part in a focus group either at the clinic or online (via Teams/ zoom) at the end of the program.

Other: Healthy Body & Mind Program
12-week physical activity and lifestyle education program

No Intervention: Wait-list control

Usual care. Participants will not be recruited if they are taking part in another research intervention or receiving treatment other than usual care.

Outcome Measures

Primary Outcome Measures

  1. Health-related quality of life questionnaire [12 weeks]

    EuroQoL health-related quality of life (EQ-5D; https://euroqol.org/); Score range 0-1; 1 indicating full health, 0 indicating bad health.

Secondary Outcome Measures

  1. Cognition questionnaire [12 weeks]

    Montreal Cognitive Assessment (MoCA); Score range 0-30; higher scores mean better cognition. Measure can also be broken down into subscales.

Other Outcome Measures

  1. Chronic pain questionnaire [12 weeks]

    Western Ontario and McMaster Universities Arthritis Index (WOMAC); Score range 0-96; 0 represents best health, higher scores indicate more pain. Measure can also be broken down into subscales (e.g., pain and function).

  2. Depression, anxiety & stress questionnaire [12 weeks]

    Depression Anxiety Stress Scales (DASS-21); Score range 0-21; higher scores mean worse psychological health. Measure can also be broken down into subscales: depression, anxiety & stress.

  3. Physical function: 6-minute walk test [12 weeks]

    Assesses distance in metres walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance. Higher number of metres walked means better physical function and aerobic capacity.

  4. Cardiovascular disease (CVD) risk profile questionnaire [12 weeks]

    ADCVD (https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/). Tool calculated % risk, higher % indicates greater risk for CVD.

  5. Sleep questionnaire [12 weeks]

    Pittsburgh Sleep Quality Index (PSQI); Score range 0-21; higher scores indicate worse sleep)

  6. Physical function: handgrip strength physical test [12 weeks]

    Accesses physical strength in kilograms (kg). Average score of 3 attempts on each hand using a dynamometer; higher kg indicates more strength.

  7. Physical function: single leg stance test (balance) physical test [12 weeks]

    Physical test used to assess static postural and balance control. The participant must stand unassisted on one leg and is timed in seconds from the time one foot is flexed off the floor to the time when it touches the ground or the standing leg or an arm leaves the hips. Higher number of seconds indicates better balance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults aged 55 or above.

  • Montreal Cognitive Assessment score 18-25 indicating mild cognitive decline or mild dementia.

  • Diagnosed with osteoarthritis.

  • Able to safely undertake study assessments and complete exercise without assistance.

Exclusion Criteria:
  • Montreal Cognitive Assessment score below 18.

  • Display an abnormal cardiovascular response to exercise (as seen during the baseline exercise test) and your doctor does not provide medical clearance to exercise.

  • Are unable to speak English and do not have a translator.

  • Have orthopedic or neuromuscular limitations that prevent you from performing the exercise.

  • Are deemed unsuitable for group exercise sessions following initial assessment by an Accredited Exercise Physiologist within the UNSW Lifestyle Clinic.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UNSW Medicine & Health Lifestyle Clinic Sydney New South Wales Australia 2052

Sponsors and Collaborators

  • The University of New South Wales

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Claire Burley, Principal Investigator Dr Claire Burley, The University of New South Wales
ClinicalTrials.gov Identifier:
NCT06070818
Other Study ID Numbers:
  • HC230506
First Posted:
Oct 6, 2023
Last Update Posted:
Oct 6, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Claire Burley, Principal Investigator Dr Claire Burley, The University of New South Wales
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 6, 2023